Innate immunity in Sjögren's syndrome

Copyright © 2017 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 182(2017) vom: 15. Sept., Seite 4-13
1. Verfasser: Kiripolsky, Jeremy (VerfasserIn)
Weitere Verfasser: McCabe, Liam G, Kramer, Jill M
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2017
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Review Research Support, Non-U.S. Gov't A253 Innate immunity Sjögren's syndrome Submandibular gland Toll-like receptor
LEADER 01000caa a22002652 4500
001 NLM270837949
003 DE-627
005 20250221120232.0
007 cr uuu---uuuuu
008 231224s2017 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2017.04.003  |2 doi 
028 5 2 |a pubmed25n0902.xml 
035 |a (DE-627)NLM270837949 
035 |a (NLM)28396235 
035 |a (PII)S1521-6616(16)30654-4 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Kiripolsky, Jeremy  |e verfasserin  |4 aut 
245 1 0 |a Innate immunity in Sjögren's syndrome 
264 1 |c 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 06.11.2017 
500 |a Date Revised 27.03.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2017 Elsevier Inc. All rights reserved. 
520 |a Sjögren's syndrome (SS) is an autoimmune disease of exocrine tissue that primarily affects women. Although patients typically experience xerostomia and xerophthalmia, numerous systemic disease manifestations are seen. Innate immune hyperactivity is integral to many autoimmune diseases, including SS. Results from SS mouse models suggest that innate immune dysregulation drives disease and this is a seminal event in SS pathogenesis. Findings in SS patients corroborate those in mouse models, as innate immune cells and pathways are dysregulated both in exocrine tissue and in peripheral blood. We will review the role of the innate immune system in SS pathogenesis. We will discuss the etiology of SS with an emphasis on innate immune dysfunction. Moreover, we will review the innate cells that mediate inflammation in SS, the pathways implicated in disease, and the potential mechanisms governing their dysregulation. Finally, we will discuss emerging therapeutic approaches to target dysregulated innate immune signaling in SS 
650 4 |a Journal Article 
650 4 |a Review 
650 4 |a Research Support, Non-U.S. Gov't 
650 4 |a A253 
650 4 |a Innate immunity 
650 4 |a Sjögren's syndrome 
650 4 |a Submandibular gland 
650 4 |a Toll-like receptor 
700 1 |a McCabe, Liam G  |e verfasserin  |4 aut 
700 1 |a Kramer, Jill M  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 182(2017) vom: 15. Sept., Seite 4-13  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:182  |g year:2017  |g day:15  |g month:09  |g pages:4-13 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2017.04.003  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 182  |j 2017  |b 15  |c 09  |h 4-13